Dr. Dan Selchen discusses new insights into early diagnosis of MS and assessing a patient’s long-term prognosis while at ECTRIMS 2015 in Barcelona, Spain.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
Determining an MS Patient's Long-Term Prognosis
Media formats available:
Details
Comments
Publication Dates
Release Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
